Corrigendum: Combination effect of engineered endolysin EC340 with antibiotics.

Hye-Won Hong1,2, Young Deuk Kim1, Jaeyeon Jang1

  • 1LyseNTech Co., Ltd., Seongnam-si, South Korea.

Frontiers in Microbiology
|September 18, 2023
PubMed
Summary

This study corrects a previous article DOI. The corrected DOI is 10.3389/fmicb.2022.821936 for improved citation and discoverability.